In the article cited above, a composition error resulted in incorrect data presentation in Table 2. The following text in the column “Pharmacologic management of multisystem inflammation and coagulopathy” applies to patient nos. 4, 5, and 6: “Bicarbonate for associated AKI in patient 4 only. Methylprednisolone pulse therapy at 30 mg/kg for 3 days with tapering over 3 weeks. Slow infusion of IVIG on 2 g/kg over 2 days. Anakinra (3 mg/kg/day for 5 days) for patients 5 and 6. Furosemide, captopril, and a short course of digoxin. Enoxaparin and low-dose aspirin.”

The editors apologize for the error.

The online version of the article ( has been updated to correct the error.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at